CHARACTERISTIC | CA‑MRSA | HA-MRSA |
---|---|---|
Time and location of emergence2,6–8,10–14,22,23 | 1980s–1990s, in the community | 1960s, in hospitals |
Genotype2,23–27 | SCCmec types IV and V | SCCmec types I, II, and III |
Virulence factors23,26–30 | Panton-Valentine leukocidin often present; other virulence factors believed to exist | Uncommon |
Common subtypes19,24,25,27,29 | CMRSA-10 (USA300), CMRSA-7 (USA400) | CMRSA-2 (USA100) |
Predominant type of infection2,7,27,28,31 | Skin and soft tissue infections | Respiratory tract, urinary tract, bloodstream, and postsurgical infections |
Infection onset2,8,15,30,32 | Typically in the community in young, healthy individuals | Typically in hospital, often associated with older age, intensive care unit stay, and central lines |
Antibiotic susceptibility4,27,30,33 | Susceptible to a range of antibiotics | Limited range of antibiotic susceptibility |
Risk factors | Community risk factors25,34
| Health care risk factors26,27
|
CA‑MRSA—community-associated methicillin-resistant Staphylococcus aureus, CMRSA—Canadian epidemic strain, HA-MRSA—health care–associated methicillin-resistant Staphylococcus aureus, SCCmec—staphylococcal chromosomal cassette mec.